Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mold

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1988
Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350C Mold, B M Bradt, G R Nemerow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cellsC Mold, G R Nemerow, B M Bradt, et al.
Immunology|September 30, 2000
Structure/function studies of human decay-accelerating factorW G Brodbeck, L Kuttner-Kondo, C Mold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attackW G Brodbeck, C Mold, J P Atkinson, et al.
Immunology|May 1, 1987
C-reactive protein is involved in natural killer cell-mediated lysis but does not mediate effector-target cell recognitionL L Baum, B Johnson, S Berman, et al.
Molecular Immunology|July 1, 1992
Hamster female protein binding to chromatin, histones and DNAL Saunero-Nava, J E Coe, C Mold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1992
Serum amyloid P component binds to histones and activates the classical complement pathwayP S Hicks, L Saunero-Nava, T W Du Clos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1996
Localization of classical and alternative pathway regulatory activity within the decay-accelerating factorW G Brodbeck, D Liu, J Sperry, et al.
Clinical Immunology and Immunopathology|January 1, 1994
Decreased autoantibody levels and enhanced survival of (NZB x NZW) F1 mice treated with C-reactive proteinT W Du Clos, L T Zlock, P S Hicks, et al.
Clinical and Experimental Immunology|November 1, 1983
The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infectionS Nakayama, H Gewurz, T Holzer, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1988
Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350C Mold, B M Bradt, G R Nemerow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cellsC Mold, G R Nemerow, B M Bradt, et al.
Immunology|September 30, 2000
Structure/function studies of human decay-accelerating factorW G Brodbeck, L Kuttner-Kondo, C Mold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attackW G Brodbeck, C Mold, J P Atkinson, et al.
Immunology|May 1, 1987
C-reactive protein is involved in natural killer cell-mediated lysis but does not mediate effector-target cell recognitionL L Baum, B Johnson, S Berman, et al.
Molecular Immunology|July 1, 1992
Hamster female protein binding to chromatin, histones and DNAL Saunero-Nava, J E Coe, C Mold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1992
Serum amyloid P component binds to histones and activates the classical complement pathwayP S Hicks, L Saunero-Nava, T W Du Clos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1996
Localization of classical and alternative pathway regulatory activity within the decay-accelerating factorW G Brodbeck, D Liu, J Sperry, et al.
Clinical Immunology and Immunopathology|January 1, 1994
Decreased autoantibody levels and enhanced survival of (NZB x NZW) F1 mice treated with C-reactive proteinT W Du Clos, L T Zlock, P S Hicks, et al.
Clinical and Experimental Immunology|November 1, 1983
The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infectionS Nakayama, H Gewurz, T Holzer, et al.
Pageof 7